Cellular & Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Biomark Med. 2014;8(2):259-67. doi: 10.2217/bmm.13.118.
Our study aimed to evaluate the possible association between four miRNA polymorphisms, hsa-miR-146a (rs2910164 G>C), hsa-miR-499 (rs3746444 T>C) and hsa-miRNA-196a2 (rs11614913 C>T and rs185070757 T>G), and susceptibility to breast cancer in an Iranian population.
MATERIALS & METHODS: In this case-control study we enrolled 236 patients with breast cancer and 203 healthy individuals. Tetra primer amplification refractory mutation system PCR was applied for genotyping the four miRNA SNPs.
Our study indicated that the hsa-mir-499 rs3746444 CC homozygote increased the risk of breast cancer in the dominant (odds ratio [OR]: 2.42; 95% CI: 1.43-4.09; p = 0.001; CC vs TT) and recessive (OR: 2.48; 95% CI: 1.49-4.13; p = 0.004; CC vs TT+TC) inheritance models tested. In addition, the rs3746444 C allele increased the risk of breast cancer (OR: 1.71; 95% CI: 1.27-2.29; p = 0.0004) in comparison with the T allele. However, distribution of the rs2910164 G>C, rs11614913 C>T and rs185070757 T>G genotypes was not statistically different between cases and controls (p > 0.05).
Our findings demonstrated that the hsa-mir-499 rs3746444 polymorphism is associated with higher risk of developing breast cancer in our population.
本研究旨在评估四个 miRNA 多态性(hsa-miR-146a(rs2910164G>C)、hsa-miR-499(rs3746444T>C)和 hsa-miRNA-196a2(rs11614913C>T 和 rs185070757T>G)与伊朗人群乳腺癌易感性之间的可能关联。
在这项病例对照研究中,我们纳入了 236 例乳腺癌患者和 203 名健康个体。应用四引物扩增受阻突变系统 PCR 对四个 miRNA SNP 进行基因分型。
本研究表明,hsa-mir-499 rs3746444CC 纯合子增加了乳腺癌的发病风险(显性遗传模型:优势比[OR]:2.42;95%可信区间[CI]:1.43-4.09;p=0.001;CC 与 TT 比较;隐性遗传模型:OR:2.48;95%CI:1.49-4.13;p=0.004;CC 与 TT+TC 比较)。此外,与 T 等位基因相比,rs3746444C 等位基因增加了乳腺癌的发病风险(OR:1.71;95%CI:1.27-2.29;p=0.0004)。然而,rs2910164G>C、rs11614913C>T 和 rs185070757T>G 基因型在病例组和对照组之间的分布无统计学差异(p>0.05)。
我们的研究结果表明,hsa-mir-499 rs3746444 多态性与我们人群中乳腺癌发病风险增加相关。